CNBC September 20, 2023
Stefan Sykes

Key Points

– Tobacco giant Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

– The company has been making inroads into the wellness and health-care space in recent years as it pivots toward becoming a business focused on smoke-free products and respiratory medicines.

– More recently, the division has struggled, and Philip Morris has had talks with Deutsche Bank on a range of options to try to grow its wellness and health-care division.

Philip Morris International is considering selling off a stake in its largest pharmaceuticals unit.

The tobacco company, which makes Marlboro cigarettes, made inroads into the health care and wellness space in 2021 with the acquisition of Vectura, a U.K.-based pharmaceutical company...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Provider, Trends, Wellness
Wearable Tech Is Changing Fitness—Here's How Studios Can Keep Up
Modernizing health care prompts debate on paying for prevention, chronic diseases
How ‘Exercise Snacks’ Help Keep You Fit In Minutes A Day
Health Consumer Check-In: From Digital Detox to Analog Wellness, Social Re-Wilding, and a Return to the Bookstore
Emerging Trends in Consumer Wellness

Share This Article